These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29580634)

  • 1. The relationship between posttraumatic and depressive symptoms during virtual reality exposure therapy with a cognitive enhancer.
    Peskin M; Wyka K; Cukor J; Olden M; Altemus M; Lee FS; Difede J
    J Anxiety Disord; 2019 Jan; 61():82-88. PubMed ID: 29580634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.
    Difede J; Cukor J; Wyka K; Olden M; Hoffman H; Lee FS; Altemus M
    Neuropsychopharmacology; 2014 Apr; 39(5):1052-8. PubMed ID: 24217129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced exposure therapy for combat-related Posttraumatic Stress Disorder (PTSD): Study protocol for a randomized controlled trial.
    Difede J; Rothbaum BO; Rizzo AA; Wyka K; Spielman L; Jovanovic T; Reist C; Roy MJ; Norrholm SD; Glatt C; Lee F
    Contemp Clin Trials; 2019 Dec; 87():105857. PubMed ID: 31669451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer.
    Difede J; Rothbaum BO; Rizzo AA; Wyka K; Spielman L; Reist C; Roy MJ; Jovanovic T; Norrholm SD; Cukor J; Olden M; Glatt CE; Lee FS
    Transl Psychiatry; 2022 Jul; 12(1):299. PubMed ID: 35896533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Sequencing of Change in Posttraumatic Cognitions and PTSD Symptom Reduction During Prolonged Exposure Therapy.
    Kumpula MJ; Pentel KZ; Foa EB; LeBlanc NJ; Bui E; McSweeney LB; Knowles K; Bosley H; Simon NM; Rauch SA
    Behav Ther; 2017 Mar; 48(2):156-165. PubMed ID: 28270327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans.
    Rothbaum BO; Price M; Jovanovic T; Norrholm SD; Gerardi M; Dunlop B; Davis M; Bradley B; Duncan EJ; Rizzo A; Ressler KJ
    Am J Psychiatry; 2014 Jun; 171(6):640-8. PubMed ID: 24743802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD).
    Reger GM; Koenen-Woods P; Zetocha K; Smolenski DJ; Holloway KM; Rothbaum BO; Difede J; Rizzo AA; Edwards-Stewart A; Skopp NA; Mishkind M; Reger MA; Gahm GA
    J Consult Clin Psychol; 2016 Nov; 84(11):946-959. PubMed ID: 27606699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in physiological reactivity in response to the trauma memory during prolonged exposure and virtual reality exposure therapy for posttraumatic stress disorder.
    Katz AC; Norr AM; Buck B; Fantelli E; Edwards-Stewart A; Koenen-Woods P; Zetocha K; Smolenski DJ; Holloway K; Rothbaum BO; Difede J; Rizzo A; Skopp N; Mishkind M; Gahm G; Reger GM; Andrasik F
    Psychol Trauma; 2020 Oct; 12(7):756-764. PubMed ID: 32338946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between posttraumatic and depressive symptoms during prolonged exposure with and without cognitive restructuring for the treatment of posttraumatic stress disorder.
    Aderka IM; Gillihan SJ; McLean CP; Foa EB
    J Consult Clin Psychol; 2013 Jun; 81(3):375-82. PubMed ID: 23339538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder.
    de Kleine RA; Hendriks GJ; Smits JA; Broekman TG; van Minnen A
    J Psychiatr Res; 2014 Jan; 48(1):40-6. PubMed ID: 24183818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress.
    Scheeringa MS; Weems CF
    J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):69-77. PubMed ID: 24506079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prolonged exposure and virtual reality exposure on suicidal ideation in active duty soldiers: An examination of potential mechanisms.
    Norr AM; Smolenski DJ; Reger GM
    J Psychiatr Res; 2018 Aug; 103():69-74. PubMed ID: 29783077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot Study of a Telehealth-Delivered Medication-Augmented Exposure Therapy Protocol for PTSD.
    Olden M; Wyka K; Cukor J; Peskin M; Altemus M; Lee FS; Finkelstein-Fox L; Rabinowitz T; Difede J
    J Nerv Ment Dis; 2017 Feb; 205(2):154-160. PubMed ID: 27441461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttraumatic Stress Disorder Symptom Cluster Structure in Prolonged Exposure Therapy and Virtual Reality Exposure.
    Stevens ES; Bourassa KJ; Norr AM; Reger GM
    J Trauma Stress; 2021 Apr; 34(2):287-297. PubMed ID: 33128806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direction of influence between posttraumatic and depressive symptoms during prolonged exposure therapy among children and adolescents.
    Aderka IM; Foa EB; Applebaum E; Shafran N; Gilboa-Schechtman E
    J Consult Clin Psychol; 2011 Jun; 79(3):421-5. PubMed ID: 21480695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual reality exposure versus prolonged exposure for PTSD: Which treatment for whom?
    Norr AM; Smolenski DJ; Katz AC; Rizzo AA; Rothbaum BO; Difede J; Koenen-Woods P; Reger MA; Reger GM
    Depress Anxiety; 2018 Jun; 35(6):523-529. PubMed ID: 29734488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in negative cognitions mediate PTSD symptom reductions during client-centered therapy and prolonged exposure for adolescents.
    McLean CP; Yeh R; Rosenfield D; Foa EB
    Behav Res Ther; 2015 May; 68():64-9. PubMed ID: 25812826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in negative cognitions associated with PTSD predicts symptom reduction in prolonged exposure.
    Zalta AK; Gillihan SJ; Fisher AJ; Mintz J; McLean CP; Yehuda R; Foa EB
    J Consult Clin Psychol; 2014 Feb; 82(1):171-5. PubMed ID: 24188512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. You can do that?!: Feasibility of virtual reality exposure therapy in the treatment of PTSD due to military sexual trauma.
    Loucks L; Yasinski C; Norrholm SD; Maples-Keller J; Post L; Zwiebach L; Fiorillo D; Goodlin M; Jovanovic T; Rizzo AA; Rothbaum BO
    J Anxiety Disord; 2019 Jan; 61():55-63. PubMed ID: 30005843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
    de Kleine RA; Smits JA; Hendriks GJ; Becker ES; van Minnen A
    J Anxiety Disord; 2015 Aug; 34():63-7. PubMed ID: 26121495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.